Merck chief quits as further material on Vioxx emerges

Vioxx, the implosion of Merck, and aftershocks at the FDA.

Merck's Actions Surrounding Vioxx

Abdul Moiz Khan The problems of the overwhelming amount of medical literature have been thoughtfully highlighted in the PLoS Medicine editorial “Drowning or Thirsting: The Extremes of Availability of Medical Information” [1]. It is of vital importance to medical professionals that they improve on their skills of sifting through the huge amounts of literature that are made available to them ever...

The fallout from Vioxx.

Merck Animal Health

Lancaster R.T., Foxcroft, G.R., Boland, M.R, Edwards, S. and Gordon, I., 1985. Fertility of sows treated with exogenous estradiol and/or gonadotropins to control postweaning estrus. Anim. Reprod. Sci., 8:365-373 In the first of two experiments 28 multiparous sows were allocated to one of the following treatments two days after weaning at approximately 35 days postpartum: (1) untreated; (2) i.m....

Editorial: Looking Back on a Year as Editor-in-Chief.

A year ago I took on the role of Editor-in-Chief of The Journal of Neuroscience and began my tenure by writing an editorial entitled, “A Commitment to Communication.” In that editorial I outlined a number of plans for new initiatives agreed upon by the editorial board, along with my promise to be as transparent as possible about changes and processes at JNeurosci. Since that time, I have writte...